BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17196751)

  • 1. Relationships between locomotor activation and alterations in brain temperature during selective blockade and stimulation of dopamine transmission.
    Brown PL; Bae D; Kiyatkin EA
    Neuroscience; 2007 Mar; 145(1):335-43. PubMed ID: 17196751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine-dependent and dopamine-independent actions of cocaine as revealed by brain thermorecording in freely moving rats.
    Kiyatkin EA; Brown PL
    Eur J Neurosci; 2005 Aug; 22(4):930-8. PubMed ID: 16115216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain temperature responses to salient stimuli persist during dopamine receptor blockade despite a blockade of locomotor responses.
    Kiyatkin EA
    Pharmacol Biochem Behav; 2008 Dec; 91(2):233-42. PubMed ID: 18727935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of dopamine and opioid receptor blockade on motivated Coca-Cola drinking behavior and associated changes in brain, skin and muscle temperatures.
    Kiyatkin EA
    Neuroscience; 2010 May; 167(2):439-55. PubMed ID: 20167257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of peripheral and central sodium channels in mediating brain temperature fluctuations induced by intravenous cocaine.
    Kiyatkin EA; Brown PL
    Brain Res; 2006 Oct; 1117(1):38-53. PubMed ID: 16956595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditioned locomotion induced by unilateral intrastriatal administration of apomorphine: D(2) receptor activation is critical but not the expression of the unconditioned response.
    Dias FR; Carey RJ; Carrera MP
    Brain Res; 2006 Apr; 1083(1):85-95. PubMed ID: 16530737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of D1 dopamine receptors in the medial prefrontal cortex attenuates amphetamine- and methamphetamine-induced locomotor activity in the rat.
    Hall DA; Powers JP; Gulley JM
    Brain Res; 2009 Dec; 1300():51-7. PubMed ID: 19733155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apomorphine and pergolide induce hypothermia by stimulation of dopamine D-2 receptors.
    Ogren SO; Fuxe K
    Acta Physiol Scand; 1988 May; 133(1):91-5. PubMed ID: 3067517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
    Millan MJ; Newman-Tancredi A; Brocco M; Gobert A; Lejeune F; Audinot V; Rivet JM; Schreiber R; Dekeyne A; Spedding M; Nicolas JP; Peglion JL
    J Pharmacol Exp Ther; 1998 Oct; 287(1):167-86. PubMed ID: 9765336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced apomorphine sensitivity and increased binding of dopamine D2 receptors in nucleus accumbens in prepubertal rats after neonatal blockade of the dopamine D3 receptors by (+)-S14297.
    Flores-Tochihuitl J; Vargas G; Morales-Medina JC; Rivera G; De La Cruz F; Zamudio S; Flores G
    Synapse; 2008 Jan; 62(1):40-9. PubMed ID: 17957737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine action in the substantia nigra pars reticulata: iontophoretic studies in awake, unrestrained rats.
    Windels F; Kiyatkin EA
    Eur J Neurosci; 2006 Sep; 24(5):1385-94. PubMed ID: 16987223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT; White FJ
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopaminergic modulation of risk-based decision making.
    St Onge JR; Floresco SB
    Neuropsychopharmacology; 2009 Feb; 34(3):681-97. PubMed ID: 18668030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions.
    Broening HW; Morford LL; Vorhees CV
    Synapse; 2005 May; 56(2):84-93. PubMed ID: 15714503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal dopamine receptors modulate the motor activation and the increase in dopamine levels in the rat nucleus accumbens evoked by chemical stimulation of the ventral hippocampus.
    Zornoza T; Cano-Cebrián MJ; Miquel M; Aragón C; Polache A; Granero L
    Neuropsychopharmacology; 2005 May; 30(5):843-52. PubMed ID: 15689964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM; Bruno JP
    Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locomotor activity and cocaine-seeking behavior during acquisition and reinstatement of operant self-administration behavior in rats.
    Koeltzow TE; Vezina P
    Behav Brain Res; 2005 May; 160(2):250-9. PubMed ID: 15863221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between adenosine and dopamine receptor antagonists with different selectivity profiles: Effects on locomotor activity.
    Collins LE; Galtieri DJ; Collins P; Jones SK; Port RG; Paul NE; Hockemeyer J; Müller CE; Salamone JD
    Behav Brain Res; 2010 Aug; 211(2):148-55. PubMed ID: 20211657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic and serotonergic autoreceptor stimulation effects are equivalent and additive in the suppression of spontaneous and cocaine induced locomotor activity.
    Carey RJ; DePalma G; Damianopoulos E; Hopkins A; Shanahan A; Müller CP; Huston JP
    Brain Res; 2004 Sep; 1019(1-2):134-43. PubMed ID: 15306247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine and benzodiazepine-dependent mechanisms regulate the EtOH-enhanced locomotor stimulation in the GABAA alpha1 subunit null mutant mice.
    June HL; Foster KL; Eiler WJ; Goergen J; Cook JB; Johnson N; Mensah-Zoe B; Simmons JO; June HL; Yin W; Cook JM; Homanics GE
    Neuropsychopharmacology; 2007 Jan; 32(1):137-52. PubMed ID: 16710315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.